| Title |
Xpert MTB/RIF and Xpert Ultra assays for screening for pulmonary tuberculosis and rifampicin resistance in adults, irrespective of signs or symptoms
|
|---|---|
| Published in |
Cochrane database of systematic reviews, March 2021
|
| DOI | 10.1002/14651858.cd013694.pub2 |
| Pubmed ID | |
| Authors |
Adrienne E Shapiro, Jennifer M Ross, Mandy Yao, Ian Schiller, Mikashmi Kohli, Nandini Dendukuri, Karen R Steingart, David J Horne |
X Demographics
The data shown below were collected from the profiles of 27 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 8 | 30% |
| United Kingdom | 3 | 11% |
| India | 2 | 7% |
| Canada | 1 | 4% |
| Indonesia | 1 | 4% |
| Switzerland | 1 | 4% |
| Kenya | 1 | 4% |
| Unknown | 10 | 37% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 16 | 59% |
| Practitioners (doctors, other healthcare professionals) | 5 | 19% |
| Scientists | 5 | 19% |
| Science communicators (journalists, bloggers, editors) | 1 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 187 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 187 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 19 | 10% |
| Student > Bachelor | 16 | 9% |
| Student > Master | 14 | 7% |
| Other | 12 | 6% |
| Student > Ph. D. Student | 11 | 6% |
| Other | 30 | 16% |
| Unknown | 85 | 45% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 57 | 30% |
| Immunology and Microbiology | 10 | 5% |
| Social Sciences | 6 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 3% |
| Nursing and Health Professions | 3 | 2% |
| Other | 15 | 8% |
| Unknown | 91 | 49% |
Attention Score in Context
This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 November 2021.
All research outputs
#2,352,301
of 25,660,026 outputs
Outputs from Cochrane database of systematic reviews
#4,840
of 13,149 outputs
Outputs of similar age
#61,964
of 455,061 outputs
Outputs of similar age from Cochrane database of systematic reviews
#76
of 166 outputs
Altmetric has tracked 25,660,026 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,149 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.7. This one has gotten more attention than average, scoring higher than 63% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 455,061 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 166 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.